Institute Group Leaders awarded promotions by the University
We are delighted to announce that Florian Markowetz and Nitzan Rosenfeld have been promoted to Professors in the University of Cambridge Senior Academic Promotions.
Both have been assigned to the Department of Oncology, where their professorships will take effect from 1 October 2022.
Florian MarkowetzĀ has been promoted toĀ Professor of Computational Oncology, in the Department of Oncology. His team develops computational methods to link genomic profiles with quantitative measures of phenotypes, leading towards a comprehensive systems genetics understanding of cancer.
Nitzan RosenfeldĀ has been promoted toĀ Professor within the Department of Oncology. Nitzanās expertise is in liquid biopsy and translational cancer research. His research group has established applications of circulating tumour DNA (ctDNA) sequencing to analyze ctDNA from blood samples of cancer patients.
Related News
See all news-
Hot flush treatment has anti-breast cancer activity, study finds
5th January 2026
A drug mimicking the hormone progesterone has anti-cancer activity when used together with conventional anti-oestrogen treatment for women with breast cancer, a new Cambridge-led trial has found.
Find out more -
Dr Richard Mair to co-lead Ā£13.7M investment for brain tumour research
19th December 2025
The National Institute for Health and Care Research (NIHR) has today announced a Ā£13.7 million investment that will support ground-breaking research to develop novel brain tumour treatments in the UK.
Find out more -
Order of cancer-driving mutations affects the chance of tumour developmentĀ
3rd December 2025
New research from the Winton Group has revealed that the order of cancer-driving mutations plays an important role in whether tumours in the intestine can develop.
Find out more